← Open Payments lookup

EMILY GITAU: Open Payments

NPI 1275055584 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$749 in 48 payments from 13 companies in 2025. Trend: 2023 $13 · 2024 $408 · 2025 $749

Food & beverage: $749
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$153
Takeda Pharmaceuticals U.S.A., Inc.10$136
Alkermes, Inc.5$83
ABBVIE INC.5$78
E.R. Squibb & Sons, L.L.C.3$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$45
Neurocrine BioSciences, Inc.2$43
Neos Therapeutics, LP2$35
Teva Pharmaceuticals USA, Inc.2$34
Tris Pharma Inc2$31

Products named: TRINTELLIX, REXULTI, ARISTADA, VRAYLAR, CAPLYTA, ABILIFY MAINTENA, INGREZZA, Adzenys XR-ODT.

Industry payments across NY — which companies pay providers there.